Literature DB >> 19456762

Identification of granzyme B-expressing CD-8-positive T cells in lymphocytic inflammatory infiltrate in cutaneous lupus erythematosus and in dermatomyositis.

M Grassi1, F Capello, L Bertolino, Z Seia, M Pippione.   

Abstract

BACKGROUND: Lupus erythematosus (LE) and dermatomyositis (DM) are interface dermatitis, histologically characterized by formation of colloid bodies and a CD4+ CD8+ lymphocyte infiltrate. Colloid bodies are examples of intraepidermal apoptosis. Granzyme (Gr)B, synthesized by activated cytotoxic lymphocytes, is a serine protease able to prime apoptosis. GrB+ lymphocytes have been previously found in infiltrates in skin lesions from other types of interface dermatitis. AIM: To evaluate, on histological skin specimens from patients with LE and DM, GrB expression as a mediator of keratinocyte apoptosis in lymphocyte infiltrate.
METHODS: In total, 22 patients with cutaneous LE [9 with discoid lupus erythematosus (DLE), 9 with subacute lupus erythematosus (SCLE) and 4 with systemic lupus erythematosus (SLE)] and 20 patients with DM were studied. Skin specimens underwent immunohistochemical staining with antibodies to CD3, CD4, CD8 and GrB.
RESULTS: Immunohistochemical study with GrB was positive in 17 of the 22 patients with LE but only 2 of the 20 patients with DM. In LE, in systemic and subacute forms of LE, the median obtained was < 10 (+) whereas in the chronic forms, the median was 10-50% (++). Patients with DM were negative for GrB.
CONCLUSIONS: In LE, a correlation between GrB+ lymphocyte and the presence of DLE form was found, but in DM, GrB is poorly expressed. GrB labels a subpopulation of effector cells involved in ongoing cytotoxic action and should be considered as a specific marker showing the extent of the direct local cytotoxic damage. GrB could play a role in the induction of skin apoptosis mechanisms in LE.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19456762     DOI: 10.1111/j.1365-2230.2009.03297.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  16 in total

1.  Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases.

Authors:  John C Hall; Livia Casciola-Rosen; Alan E Berger; Efstathia K Kapsogeorgou; Chris Cheadle; Athanasios G Tzioufas; Alan N Baer; Antony Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-08       Impact factor: 11.205

2.  Differential expression of BAFF and its receptors in discoid lupus erythematosus patients.

Authors:  Benjamin F Chong; Lin-Chiang Tseng; Andrew Kim; Rodney T Miller; Kim B Yancey; Gregory A Hosler
Journal:  J Dermatol Sci       Date:  2013-11-16       Impact factor: 4.563

3.  Changes in T cell and B cell composition in discoid lupus erythematosus skin at different stages.

Authors:  Jack C O'Brien; Gregory A Hosler; Benjamin F Chong
Journal:  J Dermatol Sci       Date:  2016-12-05       Impact factor: 4.563

Review 4.  Immunopathogenesis of skin injury in systemic lupus erythematosus.

Authors:  Grace A Hile; J Michelle Kahlenberg
Journal:  Curr Opin Rheumatol       Date:  2021-03-01       Impact factor: 5.006

Review 5.  T cells in myositis.

Authors:  Vivianne Malmström; Paulius Venalis; Inka Albrecht
Journal:  Arthritis Res Ther       Date:  2012-12-28       Impact factor: 5.156

Review 6.  Cutaneous and systemic connections in lupus.

Authors:  Mitra P Maz; J Michelle Kahlenberg
Journal:  Curr Opin Rheumatol       Date:  2020-11       Impact factor: 4.941

Review 7.  Innate immune-response mechanisms in dermatomyositis: an update on pathogenesis, diagnosis and treatment.

Authors:  Thorsten Hornung; Joerg Wenzel
Journal:  Drugs       Date:  2014-06       Impact factor: 11.431

Review 8.  Pathophysiology of cutaneous lupus erythematosus.

Authors:  Jordan C Achtman; Victoria P Werth
Journal:  Arthritis Res Ther       Date:  2015-08-10       Impact factor: 5.156

9.  Serum concentrations of metalloproteinase 2, metalloproteinase 9 and granzyme B in contact eczema patients.

Authors:  Milena Wojciechowska; Magdalena Zbikowska-Gotz; Rafał Czajkowski; Zbigniew Bartuzi
Journal:  Postepy Dermatol Alergol       Date:  2013-04-12       Impact factor: 1.837

Review 10.  Immune response patterns in non-communicable inflammatory skin diseases.

Authors:  K Eyerich; S Eyerich
Journal:  J Eur Acad Dermatol Venereol       Date:  2018-01-15       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.